These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28703313)

  • 21. Linking transgene expression of engineered mesenchymal stem cells and angiopoietin-1-induced differentiation to target cancer angiogenesis.
    Conrad C; Hüsemann Y; Niess H; von Luettichau I; Huss R; Bauer C; Jauch KW; Klein CA; Bruns C; Nelson PJ
    Ann Surg; 2011 Mar; 253(3):566-71. PubMed ID: 21169810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prodrug cancer gene therapy.
    Altaner C
    Cancer Lett; 2008 Nov; 270(2):191-201. PubMed ID: 18502571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal stem cell: a new horizon in cancer gene therapy.
    Mohammadi M; Jaafari MR; Mirzaei HR; Mirzaei H
    Cancer Gene Ther; 2016 Sep; 23(9):285-6. PubMed ID: 27650780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted inhibition of osteosarcoma tumor growth by bone marrow-derived mesenchymal stem cells expressing cytosine deaminase/5-fluorocytosine in tumor-bearing mice.
    NguyenThai QA; Sharma N; Luong do H; Sodhi SS; Kim JH; Kim N; Oh SJ; Jeong DK
    J Gene Med; 2015; 17(3-5):87-99. PubMed ID: 25808408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Programming hMSCs into Potential Genetic Therapy in Cancer.
    Serakinci N; Cagsin H
    Crit Rev Eukaryot Gene Expr; 2019; 29(4):343-350. PubMed ID: 31679295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TRAIL based therapy: overview of mesenchymal stem cell based delivery and miRNA controlled expression of TRAIL.
    Attar R; Sajjad F; Qureshi MZ; Tahir F; Hussain E; Fayyaz S; Farooqi AA
    Asian Pac J Cancer Prev; 2014; 15(16):6495-7. PubMed ID: 25169476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer gene therapy using mesenchymal stem cells.
    Uchibori R; Tsukahara T; Ohmine K; Ozawa K
    Int J Hematol; 2014 Apr; 99(4):377-82. PubMed ID: 24578184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Harnessing mesenchymal stem cell homing as an anticancer therapy.
    Hagenhoff A; Bruns CJ; Zhao Y; von Lüttichau I; Niess H; Spitzweg C; Nelson PJ
    Expert Opin Biol Ther; 2016 Sep; 16(9):1079-92. PubMed ID: 27270211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma.
    Ryu CH; Park KY; Kim SM; Jeong CH; Woo JS; Hou Y; Jeun SS
    Biochem Biophys Res Commun; 2012 May; 421(3):585-90. PubMed ID: 22525671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal stem cells in drug/gene delivery: implications for cell therapy.
    Greco SJ; Rameshwar P
    Ther Deliv; 2012 Aug; 3(8):997-1004. PubMed ID: 22946432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetically modified mesenchymal stromal cells in cancer therapy.
    Sage EK; Thakrar RM; Janes SM
    Cytotherapy; 2016 Nov; 18(11):1435-1445. PubMed ID: 27745603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrovirus-mediated transduction of a cytosine deaminase gene preserves the stemness of mesenchymal stem cells.
    Park JS; Chang DY; Kim JH; Jung JH; Park J; Kim SH; Lee YD; Kim SS; Suh-Kim H
    Exp Mol Med; 2013 Feb; 45(2):e10. PubMed ID: 23429359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Applications of Modified Mesenchymal Stem Cells as Targeted Systems against Tumor Cells.
    Garza Treviño EN; Quiroz Reyes AG; Delgado Gonzalez P; Rojas Murillo JA; Islas JF; Alonso SS; Gonzalez Villarreal CA
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal stem cells for anti-cancer drug delivery.
    Gjorgieva D; Zaidman N; Bosnakovski D
    Recent Pat Anticancer Drug Discov; 2013 Sep; 8(3):310-8. PubMed ID: 23688246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma.
    Altanerova V; Cihova M; Babic M; Rychly B; Ondicova K; Mravec B; Altaner C
    Int J Cancer; 2012 May; 130(10):2455-63. PubMed ID: 21732344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal stem cells as the game-changing tools in the treatment of various organs disorders: Mirage or reality?
    Marofi F; Vahedi G; Hasanzadeh A; Salarinasab S; Arzhanga P; Khademi B; Farshdousti Hagh M
    J Cell Physiol; 2019 Feb; 234(2):1268-1288. PubMed ID: 30191962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetically Modified Mesenchymal Stem Cells: The Next Generation of Stem Cell-Based Therapy for TBI.
    Shahror RA; Wu CC; Chiang YH; Chen KY
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition.
    Krassikova LS; Karshieva SS; Cheglakov IB; Belyavsky AV
    J Gene Med; 2016 Sep; 18(9):220-33. PubMed ID: 27461566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma.
    Zischek C; Niess H; Ischenko I; Conrad C; Huss R; Jauch KW; Nelson PJ; Bruns C
    Ann Surg; 2009 Nov; 250(5):747-53. PubMed ID: 19826249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineered Mesenchymal Stem Cells for Targeting Solid Tumors: Therapeutic Potential beyond Regenerative Therapy.
    Cheng S; Nethi SK; Rathi S; Layek B; Prabha S
    J Pharmacol Exp Ther; 2019 Aug; 370(2):231-241. PubMed ID: 31175219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.